ML21315A003

From kanterella
Jump to navigation Jump to search
Shine Technologies, LLC, Application for an Operating License Response to Request for Additional Information
ML21315A003
Person / Time
Site: SHINE Medical Technologies
Issue date: 11/11/2021
From: Jim Costedio
SHINE Health. Illuminated, SHINE Technologies
To:
Document Control Desk, Office of Nuclear Reactor Regulation
Shared Package
ML21315A002 List:
References
2021-SMT-0161
Download: ML21315A003 (2)


Text

         

THIS LETTER CONTAINS SECURITY-RELATED INFORMATION IN ACCORDANCE WITH 10 CFR 2.390 November 11, 2021 2021-SMT-0161 10 CFR 50.30 U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555

References:

(1) SHINE Medical Technologies, LLC letter to the NRC, SHINE Medical Technologies, LLC Application for an Operating License, dated July 17, 2019 (ML19211C143)

(2) NRC letter to SHINE Medical Technologies, LLC, SHINE Medical Technologies, LLC - Request for Additional Information Related to Cyber Security (EPID No. L-2019-NEW-0004), dated August 13, 2021 (ML21210A438)

SHINE Technologies, LLC Application for an Operating License Response to Request for Additional Information Pursuant to 10 CFR Part 50.30, SHINE Technologies, LLC (SHINE) submitted an application for an operating license for a medical isotope production facility (Reference 1) to be located in Janesville, WI. The NRC staff determined that additional information was required to enable the staffs continued review of the SHINE operating license application (Reference 2).

This submittal contains security-related information which SHINE requests to be withheld from public disclosure in accordance with 10 CFR 2.390(d). Security-related information was identified utilizing the guidance contained in Regulatory Issue Summary (RIS) 2005-31, Revision 1.

Enclosure 1 provides the SHINE responses to the NRC staffs request for additional information.

Enclosure 1 contains security-related information. SHINE requests the NRC withhold Enclosure 1 from public disclosure, in its entirety, under 10 CFR 2.390.

If you have any questions, please contact Mr. Jeff Bartelme, Director of Licensing, at 608/210-1735.

Enclosure 1 contains security-related information.

Withhold from public disclosure under 10 CFR 2.390.

Upon removal of Enclosure 1, this letter is uncontrolled.

3400 Innovation Ct.

  • Janesville, WI 53546
  • 877.512.6554
  • info@shinemed.com
  • www.SHINEtechnologies.com

         

Document Control Desk Page 2 I declare under the penalty of perjury that the foregoing is true and correct.

Executed on November 11, 2021.

Very truly yours, James Costedio Vice President of Regulatory Affairs and Quality SHINE Technologies, LLC Docket No. 50-608 Enclosure cc: Project Manager, USNRC SHINE General Counsel Supervisor, Radioactive Materials Program, Wisconsin Division of Public Health (w/o Enclosure 1)